CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-22 | JANNEY DANIEL Director | Conversion | +124,456 | 455,046 | ||
| 2017-09-22 | JANNEY DANIEL Director | Conversion · Series A Convertible Preferred Stock | −124,456 | 0 | ||
| 2017-09-22 | Krishnan Suma Chief Operating Officer | Purchase | +100,000 | $10.00 | $1.0M | 1,935,249 |
| 2017-09-22 | Krishnan Suma Chief Operating Officer | Conversion | +112,162 | 112,162 | ||
| 2017-09-22 | Krishnan Suma Chief Operating Officer | Conversion · Series A Convertible Preferred Stock | −112,162 | 0 | ||
| 2017-09-22 | Krishnan Krish S President and CEO | Purchase | +100,000 | $10.00 | $1.0M | 1,935,249 |
| 2017-09-22 | Krishnan Krish S President and CEO | Conversion | +112,162 | 112,162 | ||
| 2017-09-22 | Krishnan Krish S President and CEO | Conversion · Series A Convertible Preferred Stock | −112,162 | 0 |
Page 42 of 42 · 828 trades